Page 1 of 12Free preview · 1–5

About this document

This 2018 review in The Journal of Clinical Investigation examines how mitochondrial dysfunction contributes to heart failure beyond impaired ATP production. It describes interconnected mechanisms involving metabolic flux bottlenecks, NAD+/NADH redox imbalance, protein acetylation, disrupted mitochondrial calcium homeostasis, reactive oxygen species, and inflammation. The authors explain how initially compensatory responses can become maladaptive and accelerate cardiac remodeling. Potential therapeutic approaches include metabolic modulation, mitochondria-targeted antioxidants, and restoration of NAD+ availability, with important gaps remaining between preclinical findings and clinical efficacy.

Free preview text

The first 5 pages, shown as text so search engines and readers can find this document.

Page 1

Mitochondrial dysfunction in pathophysiology of heart failure Bo Zhou, Rong Tian J Clin Invest. 2018;128(9):3716-3726. https://doi.org/10.1172/JCI120849. Mitochondrial dysfunction has been implicated in the development of heart failure. Oxidative metabolism in mitochondria is the main energy source of the heart, and the inability to generate and transfer energy has long been considered the primary mechanism linking mitochondrial dysfunction and contractile failure. However, the role of mitochondria in heart failure is now increasingly recognized to be beyond that of a failed power plant. In this Review, we summarize recent evidence demonstrating vicious cycles of pathophysiological mechanisms during the pathological remodeling of the heart that drive mitochondrial contributions from being compensatory to being a suicide mission. These mechanisms include bottlenecks of metabolic flux, redox imbalance, protein modification, ROS-induced ROS generation, impaired mitochondrial Ca2+ homeostasis, and inflammation. The interpretation of these findings will lead us to novel avenues for disease mechanisms and therapy. Review Series Find the latest version: http://jci.me/120849/pdf

Page 2

The Journal of Clinical Investigation 3 7 1 6 jci.org Volume 128 Number 9 September 2018R E V I E W S E R I E S : M I T O C H O N D R I A L D Y S F U N C T I O N I N D I S E A S E Series Editor: Michael Sack The heart is an organ with high energy demands. The majority of the ATP consumed by the heart (~95%) is derived from oxidative metabolism in the mitochondria, organelles that occupy approxi- mately one-third of the volume of adult cardiomyocytes and are colloquially known as the “powerhouses” of the cell. Mitochon- drial dysfunction has been widely observed in the failing heart irrespective of etiology. Although this dysfunction is recognized as a maladaptive response, specific mechanisms connecting mito- chondrial dysfunction and the development or progression of heart failure are complex and are not fully understood. Initially, decreased energy supply is considered the main consequence of mitochondrial dysfunction. However, recent advances have iden- tified a number of mechanisms that contribute to the pathogen- esis of heart failure beyond the notion of “power plant” failure. Here we will review some of the development in this area with an emphasis on the crosstalk between impaired bioenergetics and the maladaptive signaling circuit triggered by mitochondrial dysfunc- tion in the pathophysiology of heart failure. Overview of mitochondrial function Mitochondria are double-membraned organelles found in nearly all eukaryotic cells. A primary function of the mitochondrion is to generate ATP through oxidative phosphorylation. Oxidative phosphorylation takes place in the inner mitochondrial mem- brane, during which reducing equivalents, e.g., NADH and FADH2, are transferred from the carrier molecules to the elec- tron transport chain (ETC) while protons are pumped to the intermembrane space. Because the inner mitochondrial mem- brane is impermeable to most ions and small molecules, proton pumping generates a membrane potential that is used to convert ADP to ATP by the ATP synthase. Thus, the inner membrane impermeability and the mitochondrial membrane potential are critical properties of functioning mitochondria. To maintain oxidative phosphorylation, a variety of carbon substrates are metabolized via specific pathways that eventually converge on the tricarboxylic acid (TCA) cycle to produce reduced equivalents, e.g., NADH and FADH2. Oxidative phosphorylation also generates reactive oxygen species (ROS), which were first considered by-products but were later found to possess many (patho)physiological functions (Figure 1). Moreover, oxidative metabolism in the mitochondria is not limited to ATP generation. In certain cell types, such as brown adipocytes, uncoupling pro- teins use the mitochondrial membrane potential for thermogen- esis (1). Intermediary metabolism in the mitochondria provides metabolites for multiple biological processes, such as biosynthesis and protein modifications (refs. 2, 3, and Figure 1). Furthermore, mitochondria regulate cell signaling by modulating redox state, supplying cofactors for biochemical reactions and generating ligands for signaling transduction (4–6). Mitochondria possess active calcium transport systems, and multiple enzymes in the oxidative metabolism pathways are acti- vated by calcium. Thus, calcium is an important second messen- ger connecting contractile function and mitochondrial metabo- lism (7–11). Moreover, mitochondrial uptake of calcium has been proposed as a mechanism that maintains intracellular calcium homeostasis (12). The identification of mitochondrial calcium uni- porter (MCU) in 2011 (13, 14) stimulated an array of investigations on the role of mitochondrial calcium in health and diseases. The roles of mitochondria are not limited to supporting life; rather, they are also actively involved in initiating cell death. Stress conditions that lead to calcium or ROS overload trigger the open- ing of the mitochondrial permeability transition pore (mPTP), leading to loss of mitochondrial membrane potential (15–18). This results in failure to produce ATP and release of mitochondrial proteins such as cytochrome c, which trigger cell death through necrotic and apoptotic pathways, respectively (refs. 16, 17, 19, and Mitochondrial dysfunction has been implicated in the development of heart failure. Oxidative metabolism in mitochondria is the main energy source of the heart, and the inability to generate and transfer energy has long been considered the primary mechanism linking mitochondrial dysfunction and contractile failure. However, the role of mitochondria in heart failure is now increasingly recognized to be beyond that of a failed power plant. In this Review, we summarize recent evidence demonstrating vicious cycles of pathophysiological mechanisms during the pathological remodeling of the heart that drive mitochondrial contributions from being compensatory to being a suicide mission. These mechanisms include bottlenecks of metabolic flux, redox imbalance, protein modification, ROS-induced ROS generation, impaired mitochondrial Ca2+ homeostasis, and inflammation. The interpretation of these findings will lead us to novel avenues for disease mechanisms and therapy. Mitochondrial dysfunction in pathophysiology of heart failure Bo Zhou and Rong Tian Mitochondria and Metabolism Center, University of Washington, Seattle, Washington, USA. Conflict of interest: The authors have declared that no conflict of interest exists. Reference information: J Clin Invest. 2018;128(9):3716–3726. https://doi.org/10.1172/JCI120849.

Page 3

The Journal of Clinical InvestigationR E V I E W S E R I E S : M I T O C H O N D R I A L D Y S F U N C T I O N I N D I S E A S E 3 7 1 7jci.org Volume 128 Number 9 September 2018 oxidation is downregulated (29). Notably, ATP generated from glycolysis alone contributes less than 5% of the total ATP con- sumed in a normal adult heart (29). Thus, upregulating glycolysis is not an effective method of increasing energy supply. On the energy demand side, pathological remodeling increas- es energy expenditure through unfavorable cardiac geometry, increased neurohormonal stimulation, and impaired calcium han- dling (30, 31). Collectively, these changes disturb the homeostasis between energy supply and demand, resulting in a stress on myo- cardial energetics (Figure 2). The hypothesis that a failing heart is energy starved is consistent with such a scenario and has inspired decades of research to date (refs. 28, 32–34). Clinical evidence supporting the energy starvation hypothesis in heart failure comes from the observation that therapeutic measures to reduce energy consumption, such as vasodilators and beta blockers, improve survival in heart failure, while treatments that increase energy demand of the heart, such as inotropes, worsen the outcome (refs. 35–37 and Figure 2). Few strategies of increasing ATP supply have been tried clinically thus far (38, 39). The high-energy phosphate content of the failing heart is reduced. This is first manifested as a decrease of the energy reserve compound phosphocreatine (PCr) resulting in a lower PCr/ATP ratio (40–43). It is puzzling, however, that the ATP con- tent in a failing heart is largely maintained until the end stage (40, 42–45) despite the early signs of a mismatch between energy supply and demand. One interpretation of this observation is that myocardial energy status is sustained by “adaptive” mechanisms mobilized during the progression of heart failure (46, 47). The nature of these mechanisms is poorly understood. Whether they are ultimately adaptive warrants reevaluation. As the stressed heart goes on a downward spiral to failure despite a relatively sta- ble ATP level, it raises a possibility that mechanisms used during cardiac remodeling to restore energy homeostasis, which are either originating from or targeted to mitochondria, contribute to the vicious cycles that drive cardiac remodeling to heart failure (Figure 2). This leads to the question of whether the demise of the stressed heart is caused by energy starvation or the effort to fight starvation. In sections below, recent studies examining the meta- bolic and/or mitochondrial responses in the chronically stressed heart are reviewed to determine whether efforts to sustain energy homeostasis can be potentially costly to the failing heart and thus accelerate heart failure. These areas are also potential therapeutic opportunities (Figure 2). Bottleneck of metabolic flux in heart failure Cardiomyocytes possess a high capacity for oxidative metabolism and are capable of using a variety of carbon substrates for ATP synthesis. In a normal heart, the flux through intermediate metab- olism and oxidative phosphorylation can increase substantially to meet energy demand during high-performance activities such as exercise (48, 49). The heart is also metabolically flexible, able to adapt to fuel availability by switching its substrate preference (27). If this is the case, what are the bottlenecks that render failing hearts incapable of using these mechanisms to maintain energy homeostasis during chronic stress? A hallmark of metabolic remodeling in pathological hypertro- phy is downregulation of fatty acid oxidation and increased utiliza- Figure 1). It has been shown that mitochondria-initiated cell death is an important mechanism in heart failure (20), and the links between mitochondrial calcium content and cardiac dysfunction during chronic stress have been a focus of investigation over the past decade. Mitochondrial DNA and/or ROS have been shown to be triggers of inflammatory response (21–24). Regulation of innate immunity by mitochondrial function has been increasing- ly recognized in both cardiac and noncardiac diseases (21–25). As sterile inflammation is common in heart failure, the role of mito- chondrial function has also emerged as an important pathogenic mechanism, which will be discussed in detail below. Collectively, these observations suggest that molecular mechanisms promoting the transition of mitochondria from energy-producing to death- initiating functions (Figure 1) are key to identifying disease mech- anisms and therapeutic targets. Mitochondrial dysfunction and energy starvation in heart failure If ATP synthesis were ceased in a healthy human heart, stored ATP would sustain heartbeat for only a few seconds (26). It is therefore essential that the rate of ATP consumption is matched with the rate of ATP synthesis on a beat-to-beat basis. This is accomplished by oxidative metabolism in mitochondria using fatty acids as the primary fuel (27, 28). During pathological heart remodeling, car- diac metabolism is reprogrammed toward increased reliance on glucose with a significant increase of glycolysis, whereas fatty acid Figure 1. An overview of mitochondrial function in health and disease. Mitochondria are known as the powerhouse of the cell. Under normal conditions, oxidative metabolism in mitochondria produces ATP; it also produces heat in certain specialized cell types, such as brown adipocytes. In addition to generating ATP, intermediate metabolism in the mitochon- dria produces metabolites for biosynthesis, protein modification, and signal transduction. Oxidative phosphorylation is coupled with genera- tion of reactive oxygen species (ROS), which can either serve as molecular signals or cause cell damage and cell death. Mitochondrial metabolism is stimulated by calcium, but under pathological conditions, calcium over- load can trigger the opening of the mitochondrial permeability transition pore (mPTP). The release of mitochondrial content, such as cytochrome c, induces apoptosis, or the loss of membrane potential (a consequence of prolonged mPTP opening) causes ATP deprivation and necrosis. Leak of damage-associated molecular patterns (DAMPs), such as mitochondrial DNA and peptides, or excessive ROS generation also causes inflamma- tion that results in further tissue damage. The transition of mitochondria from a powerhouse to a death engine is key to the pathogenesis of many diseases, including heart failure (also see Figure 3).

Page 4

The Journal of Clinical InvestigationR E V I E W S E R I E S : M I T O C H O N D R I A L D Y S F U N C T I O N I N D I S E A S E 3 7 1 8 jci.org Volume 128 Number 9 September 2018 phy prevents increased reliance on glucose and thus suppresses the effects of glucose on pathological growth (58, 61). Inability to oxidize fatty acids under conditions of increased lipid availability, such as obesity and diabetes, could lead to accumulation of lipotox- ic metabolites (62). Moreover, incomplete fatty acid oxidation has been implicated in the development of insulin resistance in skeletal muscle, although similar studies in the heart are lacking (63, 64). More recently, it was observed that ketone body oxidation was increased in the failing hearts of both human and animal models (65, 66). This increase is associated with elevated circu- lating ketone levels in patients with heart failure (65, 67), sug- gesting a change in systemic metabolism. While emerging work suggests that increased ketone body oxidation is cardioprotective (68), its underlying mechanisms remain to be elucidated. Besides providing energy to compensate for reduced fatty acid oxidation, other potential mechanisms have been proposed as benefits of increased ketone body utilization, including modulation of oxi- dative stress and posttranslational modifications (68–70). Fur- thermore, oxidation of fatty acids or ketone body reduces glucose use by the heart (58, 71, 72); thus, the benefit of increasing ketone body utilization in the failing heart could also be attributed to reduced reliance on glucose. Mitochondrial oxidation reduction and protein modification Mitochondrial proteins can be modified through acylation of lysine residues by thioester-CoAs, such as acetyl-CoA, succinyl- CoA, malonyl-CoA, etc., produced by intermediary metabolism (73). The most studied modification is acetylation, although modifications by other acyl-CoAs also occur in the mitochondria (Figure 3). Increased mitochondrial protein acetylation has been found in the failing hearts of animal models and patients (74–78). A large number of proteins, including those involved in substrate oxidation, e.g., pyruvate dehydrogenase and fatty acid oxida- tion of glucose. Prior studies showed that a greater reliance on glu- cose in the failing heart led to increased glycolysis that had been uncoupled from oxidation, causing increases in lactate production and anaplerosis (29, 50). It also drives a greater flux of glucose into accessory pathways, all of which reduce the efficiency of ATP syn- thesis and exacerbate pathological remodeling (27, 29, 50). Pro- moting glucose oxidation, either directly or by inhibiting fatty acid oxidation, has been proposed as a therapeutic strategy (28, 51). Partly replacing fatty acids by glucose for energy provision was considered beneficial because ATP generation from glucose could moderately increase oxygen efficiency (52, 53). However, the capacity for glucose-derived ATP production is rather limited in adult hearts (27). Increased glucose uptake and metabolism also enables growth signaling that promotes the pathological remod- eling of the heart. A recent study showed that high intracellular glucose inhibits branched-chain amino acid (BCAA) catabolism, resulting in BCAA accumulation during the development of car- diac hypertrophy (54). Such a metabolic response is required for mTOR activation and cardiomyocyte hypertrophy. These findings imply that shifts in substrate preference to glucose support growth at the cost of contractile performance. In support of this notion, enhancing glucose uptake capacity to a superphysiological level was shown to improve myocardial energetics as well as stimulate pathological hypertrophy (55, 56). Fatty acid is the predominant fuel for the adult heart. Its long carbon chain makes fatty acid the most effective substrate for ener- gy provision. Downregulation of fatty acid oxidation pathways and accumulation of incompletely oxidized fatty acids were observed in an early stage of heart failure, suggesting a mismatch between fatty acid supply and oxidation (57). Promoting fatty acid utili- zation has been shown to be beneficial in a number of models of heart failure (58–60). However, the benefit of sustaining fatty acid oxidation is likely beyond energy supply. Recent evidence suggests that sustaining fatty acid oxidation during pathological hypertro- Figure 2. Mismatch of energy demand and generation drives the development of heart failure. In a healthy heart, energy production meets energy demand on a beat-by-beat basis. Pathological remodeling of the heart results in inefficiencies that increase energy demand but concomitantly reduce the capacity for energy supply. The subsequent metabolic remodeling in an attempt to regain energy homeostasis temporarily sustains the ATP level in the heart but likely drives the heart to failure via maladaptive circuits that produce mitochondrial stress. Current heart failure therapy aims at reducing the energy demand to alleviate the mismatch. Strategies that antagonize metabolic remodeling and/or mitochondrial stress signaling cascade could offer novel therapies. FAO, fatty acid oxidation.

Page 5

The Journal of Clinical InvestigationR E V I E W S E R I E S : M I T O C H O N D R I A L D Y S F U N C T I O N I N D I S E A S E 3 7 1 9jci.org Volume 128 Number 9 September 2018 fatty acid oxidation in failing hearts is associated with an increased level of short-chain acyl-CoAs in the myocardium (57, 66); thus, a mismatch in the supply and oxidation of acetyl-CoA may lead to increased protein acetylation (Figure 3). Another potential mechanism of protein hyperacetylation is reduced protein deacetylation, which is catalyzed by the sirtuin family of NAD+-dependent deacetylases (Figure 3). Three sirtu- in proteins are localized to the mitochondria: SIRT3, SIRT4, and SIRT5, among which SIRT3 is the predominant deacetylase (73). SIRT4 and SIRT5 have weak deacetylase function but possess demalonylase and desuccinylase activities or ADP-ribosylation function (73). Downregulation of SIRT3 has been shown in the failing heart (78, 85). Furthermore, sirtuin activity is dependent on NAD+ availability. Diminished NAD+ level and reduced NAD+/ NADH ratio have been observed in hearts with mitochondrial dysfunction and/or pathological hypertrophy (75, 86, 87). A low- er NAD+/NADH ratio decreases enzymatic activities for substrate tion enzymes, TCA cycle enzymes, and ETC proteins, have been shown to be hyperacetylated (75, 76). Protein hyperacetylation has been shown to decrease activities of succinate dehydrogenase, pyruvate dehydrogenase, ATP synthase, and malate-aspartate shuttle enzymes; additionally, hyperacetylation of oligomycin sensitivity–conferring protein (OSCP) increased the sensitivity to mPTP opening (75, 76, 78–82). Moreover, inhibition of malate- aspartate shuttle by acetylation impairs the transport of cytosolic NADH into mitochondria, thereby disrupting cytosolic redox state and glycolytic ATP production during the transition from cardiac hypertrophy to failure (76, 83). The cause of mitochondrial protein hyperacetylation in the failing heart is less understood. One possibility is the presence of excessive acyl-CoAs. It has been shown that protein acylation can either be mediated by an acyltransferase or occur nonenzymati- cally (73, 84), and in the latter case, the concentration of the acyl- CoAs is an important determinant of the modification. Reduced Figure 3. Maladaptive mechanisms connecting mitochondrial dysfunction and progression of heart failure. Inadequate stimulation of mitochondrial metabolism increases ATP generation at the expense of triggering maladaptive responses such as imbalance among substrate supply, catabolism, and oxidative phosphorylation (OXPHOS), as well as increased protein modifications by acylation such as acetylation (LysAc). Increased availability of acyl-CoA is a driver for protein modification, while the mismatch between NADH production and oxidation decreases the NAD+/NADH ratio, compromising the sirtuin deacetylase function. These effects collectively increase protein acetylation in the failing heart. Increased protein acylation, especially acetylation, impairs energy metabolism through negative feedback to substrate metabolism and OXPHOS. Further stimulation of mitochondrial metabolism under these condi- tions increases the risk of calcium overload, leads to greater ROS generation, and induces mPTP opening. Increased protein acetylation also weakens antiox- idant defense and sensitizes the mPTP to calcium or ROS. In the face of increased oxidative stress, effort to maintain the mitochondrial antioxidant system (e.g., the Gpx or Prx pathway) may divert energy metabolism away from ATP generation through nicotinamide nucleotide transhydrogenase (Nnt). Oxidative damage causes ROS-induced ROS release, leading to further injury of mitochondria. Failure to remove the damaged mitochondria results in the leak of DAMPs, such as mitochondrial DNA or peptides, that trigger an inflammatory response. NAD+/NADH redox imbalance also promotes NLRP3 inflammasome activation. The vicious cycle of these mechanisms ultimately drives mitochondria from being energy-producing to death-initiating organelles.

Tags

Doxxly editorial guide

Mitochondrial dysfunction in pathophysiology of heart failure: summary, contents and background

This guide helps you understand the scope of Mitochondrial dysfunction in pathophysiology of heart failure before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Mitochondrial dysfunction in pathophysiology of heart failure is a 12-page documentcredited to Ada L. Thackery. This 2018 review in The Journal of Clinical Investigation examines how mitochondrial dysfunction contributes to heart failure beyond impaired ATP production. It describes interconnected mechanisms involving metabolic flux bottlenecks, NAD+/NADH redox imbalance, protein acetylation, disrupted mitochondrial calcium homeostasis, reactive oxygen species, and inflammation. The authors explain how initially compensatory responses can become maladaptive and accelerate cardiac remodeling. Potential therapeutic approaches include metabolic modulation, mitochondria-targeted antioxidants, and restoration of NAD+ availability, with important gaps remaining between preclinical findings and clinical efficacy. It appears in the Science & Engineering collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Heart failure, Mitochondrial dysfunction, Cardiac metabolism, Bioenergetics, Oxidative stress, Calcium homeostasis, Inflammation, Review article with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Heart failure, Mitochondrial dysfunction, Cardiac metabolism, Bioenergetics, Oxidative stress, Calcium homeostasis, Inflammation, Review article. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 12 pages in the player.

  1. Part 1

    Heart failure

    Use this section of the reading guide to identify how Heart failure appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Mitochondrial dysfunction

    Use this section of the reading guide to identify how Mitochondrial dysfunction appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Cardiac metabolism

    Use this section of the reading guide to identify how Cardiac metabolism appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Bioenergetics

    Use this section of the reading guide to identify how Bioenergetics appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    Oxidative stress

    Use this section of the reading guide to identify how Oxidative stress appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    Calcium homeostasis

    Use this section of the reading guide to identify how Calcium homeostasis appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    Inflammation

    Use this section of the reading guide to identify how Inflammation appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Review article

    Use this section of the reading guide to identify how Review article appears in Mitochondrial dysfunction in pathophysiology of heart failure, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Ada L. Thackery

Doxxly credits Ada L. Thackery as the author or creator of Mitochondrial dysfunction in pathophysiology of heart failure. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is iscrm.uw.edu. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit iscrm.uw.edu

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Mitochondrial dysfunction in pathophysiology of heart failure, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Science & Engineering collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Science & Engineering resources

Frequently asked questions about Mitochondrial dysfunction in pathophysiology of heart failure

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Science & Engineering